173 related articles for article (PubMed ID: 28102193)
1. Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression.
Huang C; Li N; Li Z; Chang A; Chen Y; Zhao T; Li Y; Wang X; Zhang W; Wang Z; Luo L; Shi J; Yang S; Ren H; Hao J
Nat Commun; 2017 Jan; 8():14035. PubMed ID: 28102193
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent loss of HAPLN1 erodes vascular integrity via indirect upregulation of endothelial ICAM1 in melanoma.
Marino-Bravante GE; Carey AE; Hüser L; Dixit A; Wang V; Kaur A; Liu Y; Ding S; Schnellmann R; Gerecht S; Gu L; Eisinger-Mathason TSK; Chhabra Y; Weeraratna AT
Nat Aging; 2024 Mar; 4(3):350-363. PubMed ID: 38472454
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice.
Huang C; Li Z; Li N; Li Y; Chang A; Zhao T; Wang X; Wang H; Gao S; Yang S; Hao J; Ren H
Gastroenterology; 2018 Feb; 154(3):675-688. PubMed ID: 28989066
[TBL] [Abstract][Full Text] [Related]
4. LIMS1 Promotes Pancreatic Cancer Cell Survival under Oxygen-Glucose Deprivation Conditions by Enhancing HIF1A Protein Translation.
Huang C; Li Y; Li Z; Xu Y; Li N; Ge Y; Dong J; Chang A; Zhao T; Wang X; Wang H; Yang S; Xie K; Hao J; Ren H
Clin Cancer Res; 2019 Jul; 25(13):4091-4103. PubMed ID: 30679163
[TBL] [Abstract][Full Text] [Related]
5. Tumor Cell-Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer.
Das S; Shapiro B; Vucic EA; Vogt S; Bar-Sagi D
Cancer Res; 2020 Mar; 80(5):1088-1101. PubMed ID: 31915130
[TBL] [Abstract][Full Text] [Related]
6. Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma.
Liu J; Jiang W; Zhao K; Wang H; Zhou T; Bai W; Wang X; Zhao T; Huang C; Gao S; Qin T; Yu W; Yang B; Li X; Fu D; Tan W; Yang S; Ren H; Hao J
J Exp Med; 2019 Mar; 216(3):656-673. PubMed ID: 30733283
[TBL] [Abstract][Full Text] [Related]
7. IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer.
Mirlekar B; Michaud D; Searcy R; Greene K; Pylayeva-Gupta Y
Cancer Immunol Res; 2018 Sep; 6(9):1014-1024. PubMed ID: 29980536
[TBL] [Abstract][Full Text] [Related]
8. PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC.
Wang X; Li X; Wei X; Jiang H; Lan C; Yang S; Wang H; Yang Y; Tian C; Xu Z; Zhang J; Hao J; Ren H
Signal Transduct Target Ther; 2020 Apr; 5(1):38. PubMed ID: 32300119
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer cell-derived IL-35 promotes tumor progression via induction of IL-35-producing induced regulatory T cells.
Hao S; Chen X; Wang F; Shao Q; Liu J; Zhao H; Yuan C; Ren H; Mao H
Carcinogenesis; 2018 Dec; 39(12):1488-1496. PubMed ID: 30321288
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of IL-35 in inflammatory autoimmune diseases.
Su LC; Liu XY; Huang AF; Xu WD
Autoimmun Rev; 2018 Jul; 17(7):665-673. PubMed ID: 29729445
[TBL] [Abstract][Full Text] [Related]
11. Evidence for IL-35 Expression in Diffuse Large B-Cell Lymphoma and Impact on the Patient's Prognosis.
Larousserie F; Kebe D; Huynh T; Audebourg A; Tamburini J; Terris B; Devergne O
Front Oncol; 2019; 9():563. PubMed ID: 31316915
[TBL] [Abstract][Full Text] [Related]
12. Adaptive plasticity of IL-10
Sawant DV; Yano H; Chikina M; Zhang Q; Liao M; Liu C; Callahan DJ; Sun Z; Sun T; Tabib T; Pennathur A; Corry DB; Luketich JD; Lafyatis R; Chen W; Poholek AC; Bruno TC; Workman CJ; Vignali DAA
Nat Immunol; 2019 Jun; 20(6):724-735. PubMed ID: 30936494
[TBL] [Abstract][Full Text] [Related]
13. Serum concentration of interleukin-35 and its association with tumor stages and FOXP3 gene polymorphism in patients with prostate cancer.
Chatrabnous N; Ghaderi A; Ariafar A; Razeghinia MS; Nemati M; Jafarzadeh A
Cytokine; 2019 Jan; 113():221-227. PubMed ID: 30057362
[TBL] [Abstract][Full Text] [Related]
14. IL-37/ STAT3/ HIF-1α negative feedback signaling drives gemcitabine resistance in pancreatic cancer.
Zhao T; Jin F; Xiao D; Wang H; Huang C; Wang X; Gao S; Liu J; Yang S; Hao J
Theranostics; 2020; 10(9):4088-4100. PubMed ID: 32226541
[TBL] [Abstract][Full Text] [Related]
15. The mitochondrial deoxyguanosine kinase is required for cancer cell stemness in lung adenocarcinoma.
Lin S; Huang C; Sun J; Bollt O; Wang X; Martine E; Kang J; Taylor MD; Fang B; Singh PK; Koomen J; Hao J; Yang S
EMBO Mol Med; 2019 Dec; 11(12):e10849. PubMed ID: 31633874
[TBL] [Abstract][Full Text] [Related]
16. RETRACTED: HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarcinoma.
Wang H; Jia R; Zhao T; Li X; Lang M; Lan C; Wang H; Li Z; Zhou B; Wu L; Sun Y; Wang X; Ren H; Hao J
Cancer Lett; 2019 Jul; 453():10-20. PubMed ID: 30922919
[TBL] [Abstract][Full Text] [Related]
17. Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity.
Padoan A; Plebani M; Basso D
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30764482
[TBL] [Abstract][Full Text] [Related]
18. CircFOXK2 Promotes Growth and Metastasis of Pancreatic Ductal Adenocarcinoma by Complexing with RNA-Binding Proteins and Sponging MiR-942.
Wong CH; Lou UK; Li Y; Chan SL; Tong JH; To KF; Chen Y
Cancer Res; 2020 Jun; 80(11):2138-2149. PubMed ID: 32217695
[TBL] [Abstract][Full Text] [Related]
19. BACH1 Promotes Pancreatic Cancer Metastasis by Repressing Epithelial Genes and Enhancing Epithelial-Mesenchymal Transition.
Sato M; Matsumoto M; Saiki Y; Alam M; Nishizawa H; Rokugo M; Brydun A; Yamada S; Kaneko MK; Funayama R; Ito M; Kato Y; Nakayama K; Unno M; Igarashi K
Cancer Res; 2020 Mar; 80(6):1279-1292. PubMed ID: 31919242
[TBL] [Abstract][Full Text] [Related]
20. Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer.
Liang C; Shi S; Qin Y; Meng Q; Hua J; Hu Q; Ji S; Zhang B; Xu J; Yu XJ
Gut; 2020 May; 69(5):888-900. PubMed ID: 31611300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
